Get startedLog in
    Picture of Bayer AG logo

    BAYN — Bayer AG News Story

    0.000.00%
    de flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapMomentum Trap
    All News

    Brief: Bayer: U.S. FDA Grants Priority Review For Asundexian In Patients After Ischaemic Strokes

    Picture of Bayer AG logoBayer AG
    19/05/2026 07:37
    May 19 (Reuters) - BAYER AG BAYGn.DE:

GRANTED PRIORITY REVIEW BY U.S. FDA FOR ASUNDEXIAN IN PATIENTS AFTER A NON-CARDIOEMBOLIC ISCHEMIC STROKE OR TRANSIENT ISCHEMIC ATTACK

REGULATORY SUBMISSION IS BASED ON POSITIVE RESULTS FROM PHASE III OCEANIC-STROKE STUDY

Source text: ID:nBw98KGvha

Further company coverage: [BAYGn.DE]

 (Gdansk Newsroom)

 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Bayer AG

    See all news